Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 6.25p
  • 52 Week Low: 3.50p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,494,153
  • Market Cap: £20.80m

Eden Research partner in Spain gets authorisation for bio-fungicide

By Josh White

Date: Wednesday 31 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Biopesticide and crop protection technology company Eden Research announced on Wednesday that its partner in Spain and Portugal, Sipcam Iberia, has received authorisation for the sale of its bio-fungicide in Spain for use on a range of new crops, for the control of a larger number of fungal pathogens.
The AIM-traded firm said the product, known as '3LOGY' in Italy and 'Mevalone' in the rest of Europe, was authorised and marketed under the trade name 'ARAW' in Spain.

It said ARAW was authorised for use in Spain for control of the disease Botrytis cinerea - a prominent fungal pathogen affecting many plant species.

Botrytis causes annual economic losses of more than $10bn worldwide, and is a significant disease in grapes and several other crops, severely impacting crop yield and quality.

The company said the new authorisation would see ARAW used on major crops including strawberries, peppers, courgettes, aubergine, tomatoes, lettuce, brassicas, and raspberries.

Authorisation had also been given for the use of ARAW on an expanded list of diseases including powdery mildew on a range of significant horticultural crops, as well as on grapes.

Eden described Spain as a key market, with over 24% of the European Union's production of fruit and vegetables originating in the country.

The value of horticultural production alone, excluding top fruit and stone fruit, was estimated to be €10bn in the country in 2020.

"This expansion of the label for ARAW in Spain represents a meaningful increase in Eden's addressable market," said chief executive officer Sean Smith.

"Given the significance of Spain as a producer of horticultural crops in Europe, we are directly able to capitalise upon the growing trends toward sustainable agriculture and residue-free products that can be used in both organic and conventional growing systems.

"There is growing pressure within the food chain for the reduction of pesticide residues, which was pointed out in the Eurobarometer 2019 as one of the major concerns for European consumers."

For that reason, Smith said the fact that ARAW was exempt from the maximum residue limits was becoming more significant for a number of producers.

"These trends are also aligned with the EU's European Green Deal priorities, and we are pleased to help empower this shift toward sustainable, residue-free crop production in one of Europe's key agricultural markets."

At 1608 BST, shares in Eden Research were down 1.25% at 15.01p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.90p
Change Today 0.100p
% Change 2.63 %
52 Week High 6.25p
52 Week Low 3.50p
Volume 1,494,153
Shares Issued 533.35m
Market Cap £20.80m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average14.4% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average47.83% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth
53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average53.19% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Eden Research Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:54 137,044 @ 3.89p
15:54 146,222 @ 3.89p
15:39 240,000 @ 3.90p
13:26 130,000 @ 3.90p
13:26 150,000 @ 3.85p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page